TSHA Taysha Gene Therapies, Inc.

Fundamentals / CIK 0001806310 / USD

Taysha Gene Therapies, Inc. reported $5.49M in revenue and a net loss of $156.0M for the trailing twelve months ended September 30, 2026 (up 17.3% year over year), with a -2935.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TSHA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$33.66M$16.83M$0-$164.5MFY 2020 Net Income: -$60.01M2020FY 2021 Net Income: -$174.5M2021FY 2022 Revenue: $2.50MFY 2022 Net Income: -$166.0M2022FY 2023 Revenue: $15.45MFY 2023 Net Income: -$111.6M2023FY 2024 Revenue: $8.33MFY 2024 Net Income: -$89.30M2024FY 2025 Revenue: $9.77MFY 2025 Net Income: -$109.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $9.77M $8.33M $15.45M $2.50M -- --
Research & Development $86.40M $66.00M $56.78M $91.17M $131.9M $31.89M
Total Operating Expenses $120.3M $99.79M $87.89M $164.9M $173.3M $43.00M
Operating Income -$110.5M -$91.46M -$72.44M -$162.4M -$173.3M -$43.00M
EBITDA -$109.4M -$90.21M -$71.07M -$161.3M -$172.8M -$42.99M
Interest Income $9.22M $6.94M $3.57M -- -- --
Interest Expense $63K $102K $5.00M $3.80M $1.43M $28K
Income Tax Expense $0 $0 $0 $0 -- $0
Net Income -$109.0M -$89.30M -$111.6M -$166.0M -$174.5M -$60.01M
Basic EPS -$0.34 -$0.36 -$0.96 -$3.78 -$4.64 -$3.40
Diluted EPS -$0.34 -$0.36 -$0.96 -$3.78 -$4.64 -$3.40
Basic Shares Outstanding 319.7M 250.1M 116.1M 44.0M 37.7M 17.7M
Diluted Shares Outstanding 319.7M 250.1M 116.1M 44.0M 37.7M 17.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $5.49M $0 $1.99M $2.30M $2.02M
Research & Development $28.77M $38.64M $33.81M $24.95M $25.75M $20.14M $15.56M $15.32M
Total Operating Expenses $41.87M $47.35M $43.49M $33.78M $34.02M $28.74M $23.72M $21.95M
Operating Income -$41.87M -$47.35M -$43.49M -$28.30M -$34.02M -$26.75M -$21.42M -$19.93M
EBITDA -$41.67M -$46.95M -$43.19M -$28.00M -$33.82M -$26.45M -$21.14M -$19.63M
Interest Income $3.90M $2.33M $2.59M $2.87M $3.17M $1.86M $1.33M $1.70M
Interest Expense $4.0K $6.0K $9.0K $12K $15K $17K $19K $22K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$39.13M -$46.64M -$42.41M -$27.85M -$32.73M -$26.88M -$21.53M -$18.79M
Basic EPS -$0.10 -$0.13 -$0.12 -- -$0.09 -$0.09 -$0.08 --
Diluted EPS -$0.10 -$0.13 -$0.12 -- -$0.09 -$0.09 -$0.08 --
Basic Shares Outstanding 406.1M 369.0M 366.6M -- 353.3M 298.0M 269.3M --
Diluted Shares Outstanding 406.1M 369.0M 366.6M -- 353.3M 298.0M 269.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $319.8M $139.0M $143.9M $87.88M $149.1M $251.3M --
Cash & Short-Term Investments $319.8M $139.0M $143.9M $87.88M $149.1M $251.3M --
Other Current Assets $802K $308K $292K $466K $863K $331K --
Total Current Assets $324.6M $142.1M $149.9M $96.42M $159.6M $257.9M $15K
Property, Plant & Equipment, Net $6.74M $7.49M $10.83M $14.96M $50.61M $287K --
Other Non-Current Assets $183K $217K $304K $1.32M $1.11M -- --
Total Non-Current Assets $18.67M $18.23M $22.86M $29.86M $54.35M $1.00M $0
Total Assets $343.3M $160.4M $172.7M $126.3M $214.0M $258.9M $15K
Accounts Payable $6.28M $3.59M $6.37M $10.95M $21.76M $1.99M --
Deferred Revenue (Current) -- $9.77M $18.11M $33.56M -- -- --
Other Current Liabilities -- -- -- -- $1.49M $91K $21K
Total Current Liabilities $26.55M $26.23M $36.76M $62.79M $51.75M $7.13M $150K
Long-Term Debt $50.11M $43.94M $40.51M $37.97M $37.19M -- --
Other Non-Current Liabilities $1.55M $1.31M $1.58M $4.13M $3.73M $450K --
Total Non-Current Liabilities $69.83M $62.61M $61.04M $62.54M $66.83M $450K $0
Total Liabilities $96.38M $88.84M $97.79M $125.3M $118.6M $7.58M $150K
Total Debt (incl. Leases) $70.14M $63.56M $61.88M $61.06M $37.19M -- --
Common Stock $3.0K $2.0K $2.0K $1.0K -- -- --
Retained Earnings -$711.3M -$602.3M -$513.0M -$401.4M -$235.6M -$61.13M -$1.11M
Accumulated Other Comp. Income -$192K -$4.03M -- -- -- -- --
Total Stockholders' Equity $246.9M $71.53M $74.94M $949K $95.38M $251.3M -$135K
Total Equity $246.9M $71.53M $74.94M $949K $95.38M $251.3M -$135K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $422.8M $455.4M $276.6M $319.8M $297.3M $312.8M $116.6M $139.0M
Cash & Short-Term Investments $422.8M $455.4M $276.6M $319.8M $297.3M $312.8M $116.6M $139.0M
Other Current Assets $659K $851K $1.01M $802K $456K $657K $536K $308K
Total Current Assets $426.1M $461.4M $282.2M $324.6M $300.0M $316.3M $120.7M $142.1M
Property, Plant & Equipment, Net $2.53M $2.41M $6.45M $6.74M $6.80M $6.96M $7.24M $7.49M
Other Non-Current Assets $48K $106K $181K $183K $184K $186K $188K $217K
Total Non-Current Assets $8.97M $9.00M $18.10M $18.67M $16.60M $17.07M $17.65M $18.23M
Total Assets $435.0M $470.4M $300.4M $343.3M $316.6M $333.3M $138.4M $160.4M
Accounts Payable $5.59M $9.16M $4.56M $6.28M $5.44M $7.71M $4.33M $3.59M
Deferred Revenue (Current) -- -- -- -- $5.49M $5.49M $7.47M $9.77M
Total Current Liabilities $22.95M $25.98M $20.10M $26.55M $28.63M $25.35M $22.56M $26.23M
Long-Term Debt $47.33M $49.26M $48.96M $50.11M $50.85M $41.05M $42.45M $43.94M
Other Non-Current Liabilities $1.67M $1.64M $1.58M $1.55M $1.58M $1.40M $1.20M $1.31M
Total Non-Current Liabilities $55.11M $57.19M $68.31M $69.83M $68.93M $59.26M $60.75M $62.61M
Total Liabilities $78.06M $83.17M $88.41M $96.38M $97.56M $84.60M $83.30M $88.84M
Total Debt (incl. Leases) $54.59M $56.71M $68.55M $70.14M $69.08M $59.76M $61.63M $63.56M
Common Stock $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K $2.0K $2.0K
Retained Earnings -$839.5M -$800.3M -$753.7M -$711.3M -$683.4M -$650.7M -$623.8M -$602.3M
Accumulated Other Comp. Income $2.35M $769K $985K -$192K -$1.14M -$699K -$2.29M -$4.03M
Total Stockholders' Equity $357.0M $387.3M $211.9M $246.9M $219.0M $248.7M $55.06M $71.53M
Total Equity $357.0M $387.3M $211.9M $246.9M $219.0M $248.7M $55.06M $71.53M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$109.0M -$89.30M -$111.6M -$166.0M -$174.5M -$60.01M
Depreciation & Amortization $1.15M $1.25M $1.37M $1.17M $492K $9.0K
Stock-Based Compensation $13.30M $13.10M $7.91M $18.04M $18.18M $3.35M
Change in Payables -$153K -$2.92M -$2.29M -$7.80M $14.49M $1.96M
Operating Cash Flow -$93.09M -$81.22M -$73.02M -$88.39M -$117.0M -$30.73M
Capital Expenditure -$738K -$374K -$3.87M -$20.62M -$15.30M -$82K
Free Cash Flow -$93.83M -$81.60M -$76.89M -$109.0M -$132.3M -$30.81M
Investing Cash Flow -$604K -$363K -$7.35M -$24.93M -$21.55M -$9.08M
Common Stock Issued -- -- $500K -- -- --
Financing Cash Flow $274.6M $76.68M $136.4M $52.10M $39.08M $291.1M
Net Change in Cash $180.9M -$4.90M $56.02M -$61.22M -$99.51M $251.3M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$39.13M -$46.64M -$42.41M -$27.85M -$32.73M -$26.88M -$21.53M -$18.79M
Depreciation & Amortization $200K $400K $295K $299K $200K $300K $283K $304K
Stock-Based Compensation $6.08M $5.81M $5.55M $3.53M $3.29M $3.19M $3.29M $3.22M
Change in Payables -$3.56M $4.56M $1.29M -$2.13M -$1.95M $3.00M $923K -$1.50M
Operating Cash Flow -$32.91M -$40.42M -$40.88M -$26.72M -$24.17M -$20.18M -$22.02M -$18.31M
Capital Expenditure -$443K $1.0K -$24K -$250K -$108K -$2.0K -$378K $2.0K
Free Cash Flow -$33.36M -$40.42M -$40.90M -$26.97M -$24.27M -$20.18M -$22.40M -$18.31M
Investing Cash Flow -$443K $1.0K -$3.02M -$247K -$48K $62K -$371K $13K
Financing Cash Flow $785K $216.7M $711K $49.56M $8.80M $216.3M -$52K -$357K
Net Change in Cash -$32.57M $176.2M -$43.19M $22.59M -$15.42M $196.2M -$22.44M -$18.65M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1130.6% -1097.6% -468.8% -6492.7% -- --
Net Profit Margin -1115.3% -1071.6% -722.1% -6635.3% -- --
Return on Equity (ROE) -44.1% -124.8% -148.9% -17493.6% -183.0% -23.9%
Return on Assets (ROA) -31.7% -55.7% -64.6% -131.5% -81.6% -23.2%
Current Ratio 12.23x 5.42x 4.08x 1.54x 3.08x 36.17x
Quick Ratio 12.04x 5.30x 3.92x 1.40x 2.88x 35.24x
Debt to Equity 0.28x 0.89x 0.83x 64.34x 0.39x --
Revenue Growth (YoY) +17.3% -46.1% +517.5% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -2935.4% -2792.3% -1774.4% -1130.6% -1618.5% -1160.8% -1225.8% -1097.6%
Net Profit Margin -2844.6% -2728.0% -1738.4% -1115.3% -1583.7% -1145.0% -1201.1% -1071.6%
Return on Equity (ROE) -43.7% -38.6% -61.3% -44.1% -45.6% -37.3% -157.6% -124.8%
Return on Assets (ROA) -35.9% -31.8% -43.2% -31.7% -31.6% -27.8% -62.7% -55.7%
Current Ratio 18.56x 17.76x 14.04x 12.23x 10.48x 12.48x 5.35x 5.42x
Quick Ratio 18.42x 17.53x 13.76x 12.04x 10.39x 12.34x 5.17x 5.30x
Debt to Equity 0.15x 0.15x 0.32x 0.28x 0.32x 0.24x 1.12x 0.89x
Revenue Growth (YoY) -- -100.0% -100.0% +171.3% -100.0% +78.6% -32.5% -43.9%
Net Income Growth (YoY) -- -- -- -- -- -- -- -139.3%
Source: SEC EDGAR CompanyFacts (CIK 0001806310) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:27 UTC · Open in terminal